Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice-Reference-Cited by-同舟云学术

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

Published:2016-12 Issue:6 Volume:117 Page:703-707
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Bongiorno Maria Rita,Crimi Nunzio,Corrao Salvatore,Allotta Alberto,Arena Antonino,Brusca Ignazio,Heffler Enrico,Malara Giovanna,Milioto Mirella,Pistone Giuseppe,Porto Morena,Raia Emilio,Valenti Giuseppe

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference10 articles.

1. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014

2. Chronic urticaria;Greaves;N Engl J Med,1995

3. Chronic urticaria: new management options;Greenberger;World Allergy Organ J,2014

4. Autoimmune urticaria;Greaves;Clin Rev Allergy Immunol,2002

5. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria;Chang;J Allergy Clin Immunol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria;International Archives of Allergy and Immunology;2022

2. Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data;Dermatologic Therapy;2020-06-07

3. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria;Allergy, Asthma & Immunology Research;2020

4. From regulatory limitations to new opportunities: Real‐life experience on the effectiveness of short courses of omalizumab in the treatment of chronic idiopatic urticaria;Dermatologic Therapy;2019-12-26

5. Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America;World Allergy Organization Journal;2019